French Presidential Race CentreRight Candidate Edouard Philippe Emerges as Early Favorite to Counter Populist Rivals
Argus Research Highlights LongTerm Growth Potential for Applied Materials AMAT
Iran Never Bow Vow and Trump Counteroffer Rejection Intensify Middle East Tensions Raising Oil Supply Risks
Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance
Anthropic Overtakes OpenAI as Most Valuable AI Startup with 65 Billion Funding Round
Retail Hiring Surge Masks Consumer Caution April Jobs Data Sparks Concerns
BBLG Q1 2026 Earnings Narrowed Loss Beats Estimates as Bone Biologics Advances Pipeline
XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges
Citi Trends Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Stock Surges
Santacruz Silver Mining SCZM Q1 2026 Earnings EPS Misses Estimates as Stock Declines
HEI Q4 2025 Earnings EPS Surprise Beats Estimates Despite Tepid Market Response
Mister Car Wash MCW Q1 2026 Earnings EPS Surprise Beats Estimates Amid Steady Operations
Cato Corporation CATO Edges Higher Amid Modest Volume Key Levels in Focus
First Financial Bankshares FFIN Experiences Slight Pullback Amid Steady Trading
Element Solutions Inc ESI Holds Near Support as Modest Decline Suggests Consolidation Phase
Hub Group Inc HUBG Edges Higher as Logistics Sector Shows Resilience
Viatris VTRS Under Pressure Support Levels Tested After 15 Decline
Roivant Shares Surge as Company Reports Swing to Profitability
Potential SpaceX IPO Could Join Historys Largest Stock Market Debuts
AEW Double or Nothing 2026 Match Card Streaming Details and Event Strategy for May 24 PayPerView
April Jobs Report Preview Labor Market Cooling but Resilient Economists Anticipate
Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office
Elon Musk and Sam Altmans Rivalry Intensifies on Wall Street
Australia Files Record 2bn Lawsuit Against 3M Over PFAS Contamination at Defence Sites
SLMBP Q1 2026 Earnings Strong EPS Surprise of 356 Amid Stable Performance
Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes